Developing Instruments to Improve How We Predict, Diagnose, and Treat Disease

MOBILion is advancing disease diagnosis and treatment through the commercialization of instruments that significantly enhance biomarker discovery and drug development.

The company's unique ion-mobility separations technology, SLIM (Structures for Lossless Ion Manipulation), stands out for its ability to maneuver ions around corners, creating a serpentine ion path that facilitates superior separations and resolution.

SLIM operates as a high-throughput instrument, swiftly conducting specific biomolecule analyses while maintaining a compact footprint. Notably, SLIM ensures no ion loss, enabling superior separations and resolution even with minimal sample quantities.

Investing partner / fund: